Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by ANALIAS00


T.TH

RE:RE:SP vs #patients

Straight from TH's Investment Community Webcast,  page 34 from the...

February 25, 2018

T.TH

RE:RE:SP vs #patients

So: 1500 patients X $60000 = $90 000 000 sales $90 000 000 X 48% = $43 200...

February 25, 2018

T.TH

SP vs #patients

We all speculated on the share price, But not many specified the # patient it...

February 25, 2018

T.TH

RE:RE:RE:RE:stock price continues to crumble

But .... why removing it ?     They should leave it there...

February 22, 2018

T.TH

RE:RE:RE:RE:RE:RE:CYDY hits its primary endpoint

I was wondering to if there was a political reason behind the delay ? Or...

February 20, 2018

T.TH

Maximum 42 days to go ...

For Taimed this adventure started 11 years ago.  That must be very...

February 20, 2018

T.TH

RE:RE:RE:RE:RE:RE:75%... not too bad.

From the short list of 7 product, only Ibalizumab seem to have (or had) the...

February 19, 2018

T.TH

RE:RE:RE:RE:RE:75%... not too bad.

KMPH $5.80 +0.15  (+2.62%) KP201/APAP ...

February 19, 2018

T.TH

RE:RE:RE:RE:75%... not too bad.

We can see those that have the Priority review status but they removed that...

February 19, 2018

T.TH

RE:RE:RE:75%... not too bad.

This seem to be the list: https://www.biopharmcatalyst.com/calendars/fda...

February 19, 2018

T.TH

RE:RE:RE:75%... not too bad.

June 30, 2017 13:19 ET FDA Grants Priority Review to Ibalizumab So you are...

February 19, 2018

T.TH

RE:75%... not too bad.

For sure it will be a quiet monday  :) 2018 Stock Market Holidays...

February 19, 2018

T.TH

RE:Amended Statement of Ownership (sc 13g/a)

8.24% or 6 millions shares.   Thats a lot.   Not to sure...

February 13, 2018

T.TH

RE:RE:Is Taimed trading?

No image sorry:    here is the link: https://holidaystracker...

February 13, 2018

T.TH

RE:Is Taimed trading?

[img]//https://holidaystracker.com/wp-content/uploads/2017/12/taiwan-stock...

February 13, 2018

T.TH

RE:RE:RE:US stocks rocking. THERF continues to be weak

And if Taiwan Stock exchange is closed form Feb 15 to Feb 20th, I dont think...

February 12, 2018

T.TH

RE:Who will be the lucky buyers?

I bought 1000 at $6.75, my order had more but only 1000 went through at that...

February 9, 2018

T.TH

June 30, 2017 13:19 ET. FDA Grants Priority Review ....

"... A Priority Review designation means FDA’s goal is to take action on...

February 9, 2018

T.TH

RE:RE:RE:RE:Haven't posted for a while

I would add to that the question about if FDA was planning to revisit WuXi...

February 7, 2018

T.TH

RE:Haven't posted for a while

juniper88 wrote: I have been busy with personal things. Just wanted to...

February 7, 2018

Featured Company